These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 23957698)

  • 21. OPN -443C>T genetic polymorphism and tumor OPN expression are associated with the risk and clinical features of papillary thyroid cancer in a Chinese cohort.
    Mu G; Wang H; Cai Z; Ji H
    Cell Physiol Biochem; 2013; 32(1):171-9. PubMed ID: 23867349
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Common single nucleotide polymorphisms in genes related to immune function and risk of papillary thyroid cancer.
    Brenner AV; Neta G; Sturgis EM; Pfeiffer RM; Hutchinson A; Yeager M; Xu L; Zhou C; Wheeler W; Tucker MA; Chanock SJ; Sigurdson AJ
    PLoS One; 2013; 8(3):e57243. PubMed ID: 23520464
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polymorphisms in selected DNA repair genes and cell cycle regulating genes involved in the risk of papillary thyroid carcinoma.
    Halkova T; Dvorakova S; Sykorova V; Vaclavikova E; Vcelak J; Vlcek P; Sykorova P; Kodetova D; Betka J; Lastuvka P; Bavor P; Hoch J; Katra R; Bendlova B
    Cancer Biomark; 2016 Jun; 17(1):97-106. PubMed ID: 27314298
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Replication and Meta-Analysis of Common Gene Mutations in TTF1 and TTF2 with Papillary Thyroid Cancer.
    Gao Y; Chen F; Niu S; Lin S; Li S
    Medicine (Baltimore); 2015 Sep; 94(36):e1246. PubMed ID: 26356687
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pri-Mir-34b/C and Tp-53 Polymorphisms are Associated With The Susceptibility of Papillary Thyroid Carcinoma: A Case-Control Study.
    Chen P; Sun R; Pu Y; Bai P; Yuan F; Liang Y; Zhou B; Wang Y; Sun Y; Zhu J; Zhang L; Gao L
    Medicine (Baltimore); 2015 Sep; 94(38):e1536. PubMed ID: 26402809
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association between E-cadherin (CDH1) polymorphisms and papillary thyroid carcinoma risk in Han Chinese population.
    Wang YX; Zhao L; Wang XY; Liu CM; Yu SG
    Endocrine; 2012 Jun; 41(3):526-31. PubMed ID: 22194161
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of Caspase 8, Caspase 9 and Bcl-2 polymorphisms in papillary thyroid carcinoma risk in Han Chinese population.
    Wang YX; Zhao L; Wang XY; Liu CM; Yu SG
    Med Oncol; 2012 Dec; 29(4):2445-51. PubMed ID: 22120515
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The association between the Survivin A9194G exon polymorphisms and papillary thyroid carcinoma risk in the Han Chinese population.
    Wang YX; Li ML; Yu SG; Liu CM; Han Y; Wang XY
    Pathol Res Pract; 2013 Mar; 209(3):151-4. PubMed ID: 23414714
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interaction Between XRCC1 Gene Polymorphisms and Obesity on Susceptibility to Papillary Thyroid Cancer in Chinese Han Population.
    Zhu J; Qi P; Li Z
    Cell Physiol Biochem; 2018; 49(2):638-644. PubMed ID: 30165355
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A missense polymorphism (rs11466653, Met326Thr) of toll-like receptor 10 (TLR10) is associated with tumor size of papillary thyroid carcinoma in the Korean population.
    Kim SK; Park HJ; Hong IK; Chung JH; Eun YG
    Endocrine; 2013 Feb; 43(1):161-9. PubMed ID: 23124277
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between single nucleotide polymorphisms of upstream transcription factor 1 (USF1) and susceptibility to papillary thyroid cancer.
    Yuan Q; Bu Q; Li G; Zhang J; Cui T; Zhu R; Mu D
    Clin Endocrinol (Oxf); 2016 Apr; 84(4):564-70. PubMed ID: 26052935
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genotype Analyses in the Japanese and Belarusian Populations Reveal Independent Effects of rs965513 and rs1867277 but Do Not Support the Role of FOXE1 Polyalanine Tract Length in Conferring Risk for Papillary Thyroid Carcinoma.
    Nikitski AV; Rogounovitch TI; Bychkov A; Takahashi M; Yoshiura KI; Mitsutake N; Kawaguchi T; Matsuse M; Drozd VM; Demidchik Y; Nishihara E; Hirokawa M; Miyauchi A; Rubanovich AV; Matsuda F; Yamashita S; Saenko VA
    Thyroid; 2017 Feb; 27(2):224-235. PubMed ID: 27824288
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical significance of papillary thyroid cancer risk loci identified by genome-wide association studies.
    Wei WJ; Lu ZW; Wang Y; Zhu YX; Wang YL; Ji QH
    Cancer Genet; 2015 Mar; 208(3):68-75. PubMed ID: 25746573
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of the ATM gene polymorphisms with papillary thyroid cancer.
    Gu Y; Yu Y; Ai L; Shi J; Liu X; Sun H; Liu Y
    Endocrine; 2014 Apr; 45(3):454-61. PubMed ID: 23925578
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation between polymorphisms of BRAF gene and papillary thyroid carcinoma.
    Jiang R; Zhao C; Xu H; Zhao M; Sun X; Wang X; Song W
    Clin Endocrinol (Oxf); 2016 Mar; 84(3):431-7. PubMed ID: 25916409
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polymorphisms of the Highly Expressed IL-6 Gene in the Papillary Thyroid Cancer Susceptibility Among Chinese.
    Li H; Dai H; Li H; Li B; Shao Y
    Curr Mol Med; 2019; 19(6):443-451. PubMed ID: 31288714
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interleukin-10-1082 gene polymorphism is associated with papillary thyroid cancer.
    Çil E; Kumral A; Kanmaz-Özer M; Vural P; Doğru-Abbasoğlu S; Altuntaş Y; Uysal M
    Mol Biol Rep; 2014 May; 41(5):3091-7. PubMed ID: 24464184
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Onco-lncRNA HOTAIR and its functional genetic variants in papillary thyroid carcinoma.
    Zhu H; Lv Z; An C; Shi M; Pan W; Zhou L; Yang W; Yang M
    Sci Rep; 2016 Aug; 6():31969. PubMed ID: 27549736
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of chemotactic chemokine ligand 5 rs2107538 polymorphism with tuberculosis susceptibility: A meta-analysis.
    Sheng YF; Qi Q
    Innate Immun; 2020 Jul; 26(5):358-363. PubMed ID: 31874580
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of TP53 and P21 gene polymorphisms on papillary thyroid carcinoma susceptibility and clinical/pathological features.
    Heidari Z; Harati-Sadegh M; Arian A; Maruei-Milan R; Salimi S
    IUBMB Life; 2020 May; 72(5):922-930. PubMed ID: 31895498
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.